(Q36340050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Parkinson's disease: pathological mechanisms and actions of piribedil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

P Jenner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

239 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

S2-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1634907%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00819559

22 September 2019

exact match

0 references

cites work

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

12 December 2020

Evidence for a new type of dopamine receptor stimulating agent.

1 reference

12 December 2020

ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

1 reference

12 December 2020

Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.

1 reference

12 December 2020

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

Studies on piribedil in Parkinsonism

1 reference

12 December 2020

Xenobiotic metabolism in Parkinson's disease

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

12 December 2020

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

12 December 2020

Actions of dopaminergic agonists on motor function

1 reference

12 December 2020

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

1 reference

12 December 2020

1 reference

12 December 2020

Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating Agent

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro

1 reference

12 December 2020

Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent

1 reference

12 December 2020

The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

1 reference

12 December 2020

Decreased ferritin levels in brain in Parkinson's disease

1 reference

12 December 2020

Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset

1 reference

12 December 2020

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

12 December 2020

Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.

1 reference

12 December 2020

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

12 December 2020

S-methylation in motorneuron disease and Parkinson's disease

1 reference

12 December 2020

Differential labelling of dopamine receptors in rat brain in vivo: Comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine

1 reference

12 December 2020

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

12 December 2020

Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).

1 reference

12 December 2020

Action of various pharmacologic reagents on the stereotyped movements induced in rats by injection of 1-(2"-pyrimidyl)-4-piperonyl piperazine (piribedil)

1 reference

12 December 2020

Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437.

1 reference

12 December 2020

The role of environmental toxins in the etiology of Parkinson's disease

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).

1 reference

12 December 2020

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

1 reference

12 December 2020

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

12 December 2020

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

12 December 2020

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

12 December 2020

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

1 reference

12 December 2020

Identifiers

1 reference